BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34713370)

  • 1. ASO Author Reflections: Predicting Hyperthermia and Its Effect in Patients with Peritoneal Surface Malignancies.
    Guerra-Londono CE; Owusu-Agyemang P; Corrales G; Rofaeil MM; Feng L; Fournier K; Cata JP
    Ann Surg Oncol; 2022 Mar; 29(3):2100-2101. PubMed ID: 34713370
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Pleural Spread of Peritoneal Malignancies: When Heated Chemoperfusion Can Save the Day.
    Nikiforchin A; King MC; Gushchin V; Sardi A
    Ann Surg Oncol; 2021 Dec; 28(13):9136-9137. PubMed ID: 34313886
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC.
    Franko J; Ferrel B; Gorvet M
    Ann Surg Oncol; 2020 Dec; 27(13):5014-5015. PubMed ID: 32720041
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis.
    Tan JW; Thiagarajan S; Zhou S; Tan QX; Hendrikson J; Ng WH; Ng G; Liu Y; Wong JSM; Tan GHC; Soo KC; Teo MCC; Chia CS; Ong CJ
    Ann Surg Oncol; 2021 Oct; 28(11):6636-6637. PubMed ID: 33733373
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery.
    Goldberg EM; Eng OS
    Ann Surg Oncol; 2021 Nov; 28(12):7807-7808. PubMed ID: 34013481
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Achieving Long-Term Survival in Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Sarfaty E; Cohen NA
    Ann Surg Oncol; 2024 Mar; 31(3):2010-2011. PubMed ID: 38063982
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
    Mariani A; Goere D
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):818. PubMed ID: 31667730
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Safety of Abdominal Surgical Cytoreduction Combined with Locoregional Chemohyperthermia.
    Piso P
    Ann Surg Oncol; 2019 Jan; 26(1):155. PubMed ID: 30478632
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies-Surgeon Preference is Fine.
    Wiseman JT; Cloyd JM
    Ann Surg Oncol; 2020 Mar; 27(3):793-794. PubMed ID: 31691109
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications.
    Dumitra S; Lee B
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):557-558. PubMed ID: 30600405
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis.
    Powers BD; Dineen SP
    Ann Surg Oncol; 2020 Dec; 27(13):4892-4893. PubMed ID: 32318947
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Biopsychosocial Late Effects are Frequent and Negatively Impact Quality of Life Following Curatively Intended Surgery for Colorectal and Appendiceal Cancer with Peritoneal Metastases.
    Balachandran R; Thaysen HV; Christensen P; Zachariae R; Iversen LH
    Ann Surg Oncol; 2024 Mar; 31(3):1696-1697. PubMed ID: 38071710
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.
    Sluiter NR; Tuynman JB
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer.
    Sammartino P; Cornali T
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):882-883. PubMed ID: 30288653
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis.
    Baumgartner JM; Kurzrock R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):772-773. PubMed ID: 30421042
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: The Diminishing Role of Adjuvant HIPEC.
    Enomoto LM; Shen P
    Ann Surg Oncol; 2020 Jan; 27(1):115-116. PubMed ID: 31720936
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis.
    Shida D
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Current Status of Treatment of Peritoneal Carcinomatosis from Gastric Cancer Origin in Spain: Is It Possible to Cure These Patients?
    Manzanedo I; Pereira F
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):792-793. PubMed ID: 31628556
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
    Chia DKA; Ang JJ; Sundar R; Kim G; Shabbir A; So JBY; Yong WP
    Ann Surg Oncol; 2022 Dec; 29(13):8606-8607. PubMed ID: 36192514
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Time to Change: Redefining "Complete Cytoreduction" in Appendiceal Carcinomatosis.
    Munoz-Zuluaga C; King MC; Gushchin V; Sardi A
    Ann Surg Oncol; 2020 Dec; 27(13):5037-5038. PubMed ID: 32935268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.